Neonatal hypothermia in a developing country

Clinical Pediatrics
|June 1, 1980
PubMed

Insights

Hypothermia in Iraqi newborns is often linked to infection, especially in those over three days old. Early treatment with antibiotics like gentamicin is recommended for late-onset hypothermia to improve outcomes.

Area of Science:

  • Neonatal Medicine
  • Pediatric Infectious Diseases
  • Public Health in Developing Nations

Background:

  • Hypothermia is a significant risk factor for neonatal mortality.
  • Understanding precipitating factors is crucial for effective intervention in newborns.
  • Infection is a suspected cause of hypothermia in neonates, particularly in resource-limited settings.

Purpose of the Study:

  • To investigate the causes and incidence of hypothermia in newborn infants in Iraq.
  • To differentiate between early-onset and late-onset hypothermia and their associated factors.
  • To determine the mortality rates and identify key clinical findings in neonatal hypothermia.

Main Methods:

  • A prospective study of 50 newborn infants with hypothermia in Iraq.
  • Clinical assessment and laboratory investigations to identify precipitating factors, including infection.
  • Analysis of mortality rates, particularly in relation to birth weight and onset of hypothermia.

Main Results:

  • Late-onset hypothermia ( > 3 days) was frequently associated with infection, primarily septicemia.
  • Aspiration pneumonia was a common finding in late-onset hypothermia cases.
  • The overall mortality rate was 26%, with 42% mortality in low birth weight infants.
  • Early-onset hypothermia (first 3 days) was linked to cold exposure without infection and had a better prognosis.

Conclusions:

  • Late-onset neonatal hypothermia in this cohort was strongly associated with infection, necessitating prompt antibiotic treatment.
  • Empirical antibiotic therapy, including gentamicin effective against Escherichia coli, is advised for suspected late-onset hypothermia.
  • Low birth weight infants with hypothermia face a considerably higher mortality risk, highlighting the need for targeted care.